Evaluation of a blinded sample for one patient. (Center panel) Data on all peptides and proteins identified. (Surrounding panels) Distribution of only biomarkers for diabetes (model 7), CAD, and DN (RD1). According to our assessment, this sample scored as being from a patient with diabetes, early DN, and a high probability of CAD. Upon unblinding, this patient, 1757, had diabetes, was microalbuminuric, and experienced a cardiovascular event 270 days after the sample was taken.